Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
The purpose of this study is to determine the maximum tolerated dose of the chemotherapy drugs nab-paclitaxel and gemcitabine when combined with hypofractionated ablative proton therapy for the treatment of locally advanced pancreatic cancer. You will receive proton therapy once a day (Monday - Friday) for 3 weeks. Participants will also receive chemotherapy on each Monday of those three weeks.
Sponsor: University of Maryland, Baltimore
Check if you qualify for this pancreatic cancer clinical trial in Baltimore, MD
If you're searching for pancreatic cancer treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.